137 patents currently held
40 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Jan 2032. from the record
Of the 40 now held by other companies, 7 name Stmicroelectronics France as their current owner, and 33 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2032
Next term end
125
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2039 · High confidence
Also notable
Ends Apr 2037 · High confidence
Also notable
Ends Mar 2034 · High confidence
Cellular Microcompartment and Preparation Processes
US 11,807,870
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2039.
Method and Device for Detecting a Failure on an Aircraft
US 10,209,162
A family of 8 related applications built on the 2019 grant. Protection runs to 2037.
Antagonists of CB1 Receptor
US 10,150,793
The largest patent family in this portfolio, 5 related applications, renewed at 2 of 3 maintenance windows. Protection runs to 2034.
Formerly held, still cited
Notable
Ends no later than Oct 2028 · Medium confidence
Renewed at every maintenance window since the 2015 grant; no more fees are due before its term ends in 2028. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Pierre Fabre Médicament
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 5 fees due Jan 2 to 30, 2027 · next Jan 2
- 2 fees due Feb 1 to 25, 2027 · next Feb 1
- 4 fees due Mar 5 to 10, 2027 · next Mar 5
- 2 fees due Apr 8 to 30, 2027 · next Apr 8
- 2 fees due May 7, 2027
- 2 fees due Jun 10 to 30, 2027 · next Jun 10
- 4 fees due Jul 2 to 16, 2027 · next Jul 2
- 5 fees due Sep 3 to 30, 2027 · next Sep 3
- 1 fee due Oct 28, 2027The maintenance fee for Nucleoside-lipid compounds with pH-sensitive dialkylorthoester chains and their use for transportation or vectorization of at least one therapeutic agent (US 10,633,408) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
- 2 fees due Nov 7, 2027
Recent changes
- 6 of the patents on this record were granted since Aug 19, 2026
What they patent
The 5 largest of its 125 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,064,962 | Method of Monitoring the Release from Liposomes of a Product of Interest Using Superparamagnetic Nanoparticles In force · Medium confidence | In force | Medium confidence | |
| US 10,040,816 | Antagonists of CB1 Receptor In force · High confidence | In force | High confidence | |
| US 10,115,013 | Method and Apparatus for Single-Particle Localization Using Wavelet Analysis In force · High confidence | In force | High confidence | |
| US 9,117,273 | Method and Apparatus for Single-Particle Localization Using Wavelet Analysis In force · High confidence | In force | High confidence | |
| US 10,517,919 | Selective NOX-1 Inhibitor Peptides and Uses Thereof held by Universite de Bordeaux and Inserm In force · High confidence | In force | High confidence | |
| US 9,128,482 | Method and System for Detecting Jamming And/Or Uncontrolled Movement of an Aircraft Control Surface held by Airbus Operations SAS, Institut Polytechnique de Bordeaux, Centre National de la Recherche Scientifique (CNRS) and Universite de Bordeaux In force · High confidence | In force | High confidence | |
| US 10,150,793 | Antagonists of CB1 Receptor In force · High confidence | In force | High confidence | |
| US 9,631,086 | Use of Polymers as Additives in a Polymer Matrix held by Université de Bordeaux, Institut des Corps Gras Etudes et Recherches Techniques - Iterg, Centre National de la Recherche Scientifique (C.N.R.S) and Institut Polytechnique de Bordeaux In force · High confidence | In force | High confidence | |
| US 9,701,962 | Hydrophobically Modified Antisense Oligonucleotides Comprising a Ketal Group held by Institut National de la Sante et de la Recherche Medicale (Inserm), Universite de Bordeaux, Universite d'Aix-Marseille, Institut Jean Paoli & Irene Calmettes and Centre National de la Recherche Scientifique (CNRS) In force · High confidence | In force | High confidence | |
| US 9,707,250 | Hydrophobically Modified Antisense Oligonucleotides Comprising a Triple Alkyl Chain held by Institut National de la Sante et de la Recherche Medicale (Inserm), Universite de Bordeaux, Universite d'Aix-Marseille, Institut Jean Paoli & Irene Calmettes and Centre National de la Recherche Scientifique (C.N.R.S.) In force · High confidence | In force | High confidence |
Also on record, not counted in the 137: 40 patents in force now held by others · 40 patents ended · 139 applications pending · 128 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.